New Products and Industry News

Wound care product received good design award

Alliqua BioMedical, Inc (Langhorne, PA) received a GOOD DESIGN® award for its UltraMIST® Ultrasound Healing Therapy System. The Chicago Athenaeum Museum of Architecture and Design and the Metropolitan Arts Press Ltd present the Good Design Awards to the world’s leading designers to acknowledge creativity, modernization, advancement, and outstanding products that stretch the boundaries of average design.

The ultrasound system is the company’s latest addition to its line of MIST Therapy® products. This therapy involves the use of noncontact, low-frequency ultrasound delivered through a saline mist to accelerate wound healing. Unlike conventional wound treatments that are limited to treating the surface, this product delivers ultrasound energy into and below the wound bed to stimulate cells and shorten the healing process. More than 1.4 million of these treatments have been performed to date, benefiting a wide range of patients. This ultrasound system was developed in conjunction with Logic PD, a local engineering design house known for its expertise with medical devices. 

For more information, visit: https://alliqua.com. 

Bandage designed for emergency situations

OSNovative Systems, Inc (Santa Clara, CA), an advanced wound management and combat/emergency medicine products company, launched Enluxtra-E, a “smart” emergency bandage specifically designed for victims of terrorist attacks, military personnel on the battlefield, and disaster preparedness.

The emergency bandage is based on the Enluxtra™ wound dressing; its super-absorbent “smart” polymer dressing material absorbs and retains fluid even under compression to stop bleeding and deprive pathogens of water necessary for their replication. The bandage helps increase the critical 72-hour survival rate. Any wounded person can use this product as a first-line defense to control bleeding, protect the wound from infection, and boost fast healing crucial for survival. The bandage can be applied using 1 hand—no special skills are required. An easy-to-use, self-adhering elastic wrap securely holds the bandage in place. This bandage also addresses civilian emergency needs for various types of wounds as well as thermal, chemical, or radiation burns.

For more information, visit: www.enluxtrawoundcare.com. 

Company partnership to strengthen offerings in Europe

Acelity (San Antonio, TX), a global advanced wound care and regenerative medicine company, has partnered with Mediq (Utrecht, Netherlands), a leading home care and medical device delivery company, to exclusively distribute Acelity’s advanced wound care and regenerative medicine portfolio in Denmark, Finland, Norway, and Sweden. The alliance offers Acelity access to Mediq’s specialized knowledge, expertise, and network in the regions and to expand operations in the postacute environment.

The partnership leverages Mediq’s extensive experience in increasing access-to-care by offering integrated, high-quality health care services in a variety of settings, including hospitals and care institutions, pharmacies, and patients’ homes. Under the terms of the agreement, Mediq will exclusively distribute Acelity’s advanced wound care and regenerative medicine portfolio, coordinating sales, orders, and delivery.

For more information, visit: www.acelity.com. 

Italian company acquires chronic wound product

Angelini (Rome, Italy), a personal health and wellbeing manufacturer, acquired a new acid-oxidizing solution for the treatment of chronic wounds. The product comes from an exclusive partnership between Angelini and APR Applied Pharma Research (Balerna, Switzerland), the owner and developer of the proprietary, patented technology TEHCLO®, which enables the production of this acidic and super-oxidizing solution. This solution creates an unfavorable environment for the growth of microorganisms and may favor the release of oxygen in the injured tissues. 

The solution is intended for use in the debridement, irrigation, cleansing, and moistening of acute and chronic wounds (eg, diabetic foot ulcers, pressure ulcers, lower leg ulcers, vascular ulcers), postsurgical wounds, cuts, abrasions, burns, and other lesions. Because it contains hypochlorous acid as a preservative, it can prevent wound contamination by exerting a local antimicrobial effect on the wound surface. The product is certified in the EU as a Class III Medical Device.

For more information, visit: www.angelinipharma.com. 

Portable bladder ultrasound enhances diagnostic accuracy 

Verathon® Inc (Bothell, WA), a leading manufacturer and marketer of imaging and respiratory medical device solutions, launched its portable 3D ultrasound instrument: BladderScan Prime. With features such a touchscreen interface, live B-mode scanning, and onboard self-diagnostics, This device continues the brand’s long history of technological advancement, redefining accuracy, and making use by clinicians and technicians easier than ever.

The device’s design helps reduce catheter-associated urinary tract infections by reducing the use of catheters. With 1 button press, Prime’s VMODE® technology acquires multiple scan planes inside the body, producing a 3D quantification of the bladder. Based on this quantification, the instrument automatically calculates and displays urinary bladder volume.

For more information, visit: www.verathon.com. 

Technology facilitates wound healing solutions

 Gemstone Biotherapeutics LLC (Baltimore, MD), a regenerative medicine company, has exclusively licensed new wound healing technology from Johns Hopkins University. The new license will allow Gemstone Bio to develop and commercialize advanced wound healing solutions.

The technology, pioneered by Jeremy Walston, MD and Peter Abadir, MD, has the potential to provide a treatment option superior to current products to patients who are older and have diabetes-related chronic wounds. The product will target diabetic foot ulcers, a growing and costly health care dilemma. Walston and Abadir have identified a mitochondrial angiotensin receptor system that becomes less functional with age. This system likely contributes to age and disease-related declines in multiple tissue types. Physicians also discovered angiotensin receptor blockers, a category of drugs approved by the US Food and Drug Administration for hypertension, can reinvigorate this system. Building on these unique discoveries, they developed a topical agent targeting the biology that inhibits wound healing in patients who are older and have diabetes.

For more information, visit: www.gemstonebio.com. 

Antimicrobial agent developed for wound healing

Dermozone (Jakarta, Indonesia), a global wound healing and herbal skin care products company, has developed Dalethyne, a chemical-molecule compound, proven as an antimicrobial agent against most bacteria, fungi, and yeasts. This compound will be the key ingredient in the company’s MedCare range of wound healing herbal products, soon to be launched in India. The compound will be used to treat chronic skin ailments such as acne, fungal infections, dry skin, insect bites, athlete’s foot, eczema, blisters, carbuncles, and, more importantly, diabetic wounds, ulcers, and burns. 

For more information, visit: www.medcare-dermozone.co/. 

Wound filler receives CE mark

CollPlant Ltd (Ness-Ziona, Israel), a regenerative medicine company utilizing its proprietary plant-based rhCollagen (recombinant human collagen) technology for tissue repair products, received its CE Mark for Vergenix™ FG, a flowable gel intended to treat chronic and acute wounds. Previously reported clinical trial results demonstrated the gel is safe and effective for use in humans and shows excellent wound closure rates.

A doctor or nurse administers the gel to the patient through a cannula. The product’s formulation provides a scaffold of pure human collagen that fills the wound bed and is engineered to create maximal contact with the surrounding tissue, which is believed to enhance healing. The gel provides complete coverage of the wound site, facilitates wound closure through an engineered synchronization between scaffold degradation and growth of new tissue, and offers a nonallergenic and pathogen-free scaffold for safe and efficacious wound care therapy.

For more information, visit: www.collplant.com.